The present study evaluated the expression of claudin-7 in 10 intact perianal gland and 67 hyperplastic and neoplastic lesions of the canine perianal (hepatoid) gland. The results have shown intense typical membrane expression of claudin-7 in intact perianal glands, hyperplasia, adenoma, differentiated and anaplastic carcinoma of this gland. In intact glands, hyperplasias, adenomas of the hepatoid gland, normal, hyperplastic and neoplastic basal cells never expressed claudin-7 molecule. Epitheliomas of the hepatoid gland were negative for claudin-7 molecule. Intense membrane-bound claudin-7 immunoreactivity was found in well-differentiated carcinomas, in addition claudin-7 overexpression in poorly differentiated carcinomas of the canine hepatoid gland. Claudin-7 seems to be one of the integral constituents of tight junction structures of intact perianal gland. In addition, claudin-7 seems to be helpful in distinguishing well-differentiated carcinomas and poorly differentiated carcinomas from epitheliomas of the gland; and in distinguishing well-differentiated carcinomas from adenoma of the perianal gland.
transmembrane domains, and their N-and C-terminal ends are located in the cytoplasm. Claudin molecules interact with each other through homo-and heterophilic interactions. In addition, the C-terminal domain of claudins also serves as a binding site of PDZ domain proteins that are potentially involved in signalling (Hamazaki et al. 2002) .
The aim of the present study was to characterise the expression pattern of claudin-7 tight junction protein in canine intact hepatoid glands and in proliferative lesions of this gland including nodular hyperplasia, adenoma, epithelioma, well-differentiated carcinoma and poorly differentiated carcinoma.
Materials and Methods

Tissue Samples
Biopsy samples of canine hepatoid gland proliferative lesions (n = 77) were submitted for diagnosis to the Szent István University, Faculty of Veterinary Science, Department of Pathology and Forensic Veterinary Medicine. The samples were fixed in 8% neutral buffered formalin for 24 h at room temperature, dehydrated in a series of ethanol and xylene baths and embedded in paraffin wax. Sections (3-4 μm) were stained with haematoxylin and eosin (HE). We investigated intact hepatoid glands (n = 10), hepatoid gland nodular hyperplasias (n = 10), adenomas (n = 12), epitheliomas (n = 15), well differentiated hepatoid gland carcinomas (n = 15), and poorly differentiated hepatoid gland carcinomas (n = 15) from the perianal region. Histological classification of the hepatoid gland proliferative lesions was based on the book Skin Diseases of the Dog and Cat: Clinical and Histopathologic Diagnosis (Ihrke et al. 2006) . Intact hepatoid gland samples were collected from 3 female and 7 male dogs with an average age of 7.3 years (range 5-10 years). The hyperplasia study group comprised 6 females, 4 males with an average age of 9.2 years (range 8-12 years). The adenoma study group comprised 6 females and 6 males with an average age of 8.6 years (range 7-10 years).The hepatoid gland epithelioma samples were collected from 8 female and 7 male dogs with an average age of 9.9 years (range 7-13 years). The well differentiated hepatoid gland carcinoma study group comprised 9 females and 6 males with an average age of 10.7 years (range 8-15 years). The poorly differentiated hepatoid gland carcinoma samples were collected from 11 females and 4 males dogs with an average age of 12.4 years (range 9-16 years).
Immunohistochemistry
Serial sections (3-4 μm) were initially de-waxed in xylene and graded ethanol. After treatment with appropriate antigen retrieval (Target Retrieval Solution, DAKO, Glostrup, Denmark, pH 6; microwave -800 W -oven for 30 min), the sections were incubated with primary antibody against claudin-7 (diluted 1:80, rabbit polyclonal, Zymed Inc., San Francisco, CA, USA) for 60 min at room temperature. Immunohistochemical labelling was performed using the streptavidin-peroxidase procedure. Antigen-bound primary antibody was detected using standard avidin-biotin immunoperoxidase complex (DAKO, LSAB2 Kit). The chromogen substrate was 3,3'-diaminobenzidine tetrahydrochloride (DAB substrate-chromogen, DAKO). Sections were counterstained with Mayer's haematoxylin.
Negative control was performed by omission of the primary antibody and external positive control were the epithelial cells of the terminal ductulo-lobular unit from normal mammary gland tissue (Jakab et al. 2008a) . Internal positive controls were the peritumoral intact and hyperplastic apocrine glands (Plate XII, Fig. 1a-1b ) (Jakab et al. 2008b ). The peritumoural fibroblasts, endothelial cells, and lipocytes served as internal negative controls since these cells do not express claudin-7 protein.
In each case, two independent observers (CSJ and JK) recorded the distribution and intensity of labelling. 
Results
The expression of claudin-7 molecule within the different categories of proliferative lesions of hepatoid gland is summarized in Table 1 (Fig. 4) . In the intact hepatoid gland, nodular hyperplasia and adenoma, the basal cells never showed positivity for claudin-7 molecule. The epitheliomas of the canine hepatoid gland were negative for claudin-7 (Fig. 5 ). Intense lateral membrane immunoreactivity was found in the well-differentiated carcinomas (scoring: 4.2 [range = 4-5]; 60-90% tumour cell positivity). In the well-differentiated carcinomas, 10-30% tumour cells showed a fine non-granular cytoplasmic positivity for claudin-7 with or without typical membrane expression of claudin-7 protein (Plate XIII, Figs 6-7). Poorly differentiated hepatoid gland carcinomas showed an overexpression for claudin-7 (scoring: 5 [range = 5-5]; 80-100% tumour cell positivity). In poorly differentiated carcinomas, 10-40% neoplastic cells showed cytoplasmic positivity for claudin-7 with typical membrane expression for claudin-7 protein (Plate XIII, Figs 8-9). Epithelial cells of normal and hyperplastic apocrine glands showed intense membrane positivity for claudin-7 and we used these as internal positive controls. In the apocrine glands, claudin-7 immunoreactivity was stronger than in intact hepatoid glands, hyperplasias and adenomas, but it was similarly strong in differentiated and poorly differentiated carcinomas.
Discussion
Adhesion between neighbouring epithelial cells is a crucial and tightly controlled process. In epithelial cells, specialized structures such as tight junctions and adherent junctions are responsible for establishment of contacts between neighbouring cells. Claudins including claudin-7 are key components of epithelial and endothelial tight junctions, which act as a barrier to the paracellular flux of water, solutes, and transmigration of other cells. Claudins are exclusively responsible for the formation of tight junction strands and the second function of these proteins is preservation of cell polarity in the epithelial and endothelial barriers. These transmembrane proteins are connected to the actin cytoskeleton via a network of proteins such as zonula occludens-1 (ZO-1) Tsukita et al. 2002; Van Itallie et al. 2001) . These tight junction proteins have been proposed to play important roles in different biological processes including embryogenesis, development, tissue remodelling, and oncogenesis. The preservation of cell polarity and paracellular flux by many claudin molecules suggests that these proteins contribute to tumour suppressive functions in epithelial neoplasia (Karen et al. 2005) . The barrier function of the tight junctions and claudins regulates the passage of ions, water, and different macromolecules, growth factors through paracellular space. The tight junctions and claudins between epithelial cells form a polarized barrier between luminal and serosal compartments and segregate luminal growth factor from their basal-lateral receptors. This property may promote cancer formation in pre-neoplastic, pre-malignant tissues in which the tight junctions and claudins have become chronically leaky to growth factors (Mullin 1997; 2004) . The loss of claudins and other tight junction proteins has been suggested to underlie the loss of cell adhesion and to be an important step in the development of tumour invasion and metastasis (Karen et al. 2005) . Claudins have been shown to modify tumour invasion by the regulation of matrix metalloproteinases (MMPs). Several members of the claudinfamily such as claudin-2 and claudin-5 are able to activate membrane-type-1-MMPmediated pro-MMP-2 processing (Miyamori et al. 2001) .
We have reported previously that claudin-7 is one of the integral constituents of tight junction structures of normal canine mammary gland (Jakab et al. 2008a ), canine primer (Jakab et al. 2008c) , and secondary epithelial mammary gland tumours (Jakab et al. 2009 ). In the present study we examined the expression of claudin-7 in 10 normal and 67 proliferative, neoplastic lesions of the canine hepatoid gland including hepatoid gland nodular hyperplasias (n = 10), adenomas (n = 12), epitheliomas (n = 15), well differentiated hepatoid gland carcinomas (n = 15), and poorly differentiated hepatoid gland carcinomas (n = 15) from the perianal region. To our knowledge, this is the first study that has examined claudin-7 expression by intact and hepatoid gland tumours. In this study we have detected an intense membrane-expression of claudin-7 tight junction molecule in intact hepatoid glands, hyperplasias, and adenomas. Intact perianal gland and hyperplastic basal cells never showed positivity for claudin-7 molecule in these lesions. Epitheliomas of the canine hepatoid gland never expressed claudin-7 protein but intense lateral membrane immunoreactivity was found in well-differentiated carcinomas. Poorly differentiated hepatoid gland carcinomas showed overexpression for claudin-7 protein.
Claudin-7 seems to be one of the integral constituents of tight junction structures of intact perianal gland. Claudin-7 and claudin-8 are expressed normally in the distal nephron epithelium of kidneys (Li et al. 2004 ). This tight junction molecule is a novel immunohistochemical marker for renal tumour classification. The distal nephron marker claudin-7 overexpressed in human chromophobe renal cell carcinoma (RRC) versus oncocytoma and other tumour subtypes. Claudin-7 protein is a candidate expression marker for distinguishing chromophobe RRC from other renal tumour subtypes, including the morphologically similar oncocytoma (Hornsby et al. 2007 ). In our study we have found that claudin-7 molecule was never expressed in epitheliomas. Intense lateral membrane immunoreactivity was found in well-differentiated carcinomas, and anaplastic, poorly differentiated hepatoid gland carcinomas showed an overexpression for claudin-7 protein.
Claudin-7 seems to be helpful in distinguishing well-differentiated carcinomas and poorly differentiated carcinomas from epitheliomas of the canine hepatoid gland. In addition, claudin-7 can help distinguish poorly differentiated carcinomas from well-differentiated carcinomas arising from the canine hepatoid gland. Well-differentiated hepatoid gland carcinomas have a similar histological architecture and morphology to adenomas, but infiltrative growth is present at the tumour margins (Ihrke et al. 2006) . In this present study intense lateral membrane immunoreactivity was found in adenomas (scoring: 4.9; 70-100% cell positivity) and in well-differentiated carcinomas (scoring: 4.2; 60-90% cell positivity). In addition, in well-differentiated carcinomas, 10-30% tumour cells showed a cytoplasmic positivity for claudin-7 in contrast to adenoma. In our opinion, claudin-7 can help distinguish well-differentiated carcinomas from adenomas arising from the canine hepatoid gland.
Claudin-7 plays an important role in human immunodeficiency virus (HIV) infection of CD4(-) cells. This protein can serve as a receptor for HIV-1 infection of CD4(-) cells or as a ligand on the viral envelope (Zheng et al. 2005 ).
One human study described claudin-7 overexpressed in gastric dysplasia and adenocarcinoma but not in the surrounding non-neoplastic epithelial cells. These results suggest that claudin-7 expression is an early event in gastric tumourigenesis that is maintained throughout tumour progression (Johnson et al. 2005 ). This tight junction protein overexpressed in human squamous cell carcinomas of the uterine cervix (Sobel et al. 2005) as well as in the adenocarcinoma of the esophagus (Montgomery et al. 2006) . In contrast, it is underexpressed in the ductal carcinoma of the breast (Kominsky et al. 2003) . In our study we described the claudin-7 protein overexpressed in poorly differentiated hepatoid gland carcinomas. The precise mechanism behind the increased expression of claudin-7 and its biological role in canine hepatoid gland carcinogenesis will be the subject of future studies. Overexpression of claudin molecules in cancer may dysregulate cell signalling, polarity, or adhesion via interactions with other proteins (Miwa et al. 2000) . Underexpression of these proteins may reduce cell adhesion as neoplasms progress to an invasive or metastatic phenotype (Usami et al. 2006 ).
In our study we found that in well-differentiated carcinomas, 10-30% tumour cells showed a fine cytoplasmic positivity for claudin-7 with or without typical membrane expression of claudin-7 protein and in poorly differentiated carcinomas of the hepatoid gland, 10-40% neoplastic cells showed a cytoplasmic positivity for claudin-7 with typical membrane expression of claudin-7 protein. Non-junctional claudin-1 has been noted in rat epididymis (Gregory et al. 2001) , porcine brain capillary endothelial cells (Ishizaki et al. 2003) and in a selected subline of MDCK cells (Amasheh et al. 2002) . However, its function outside of tight junction in these cells is not known. In some, non-junctional claudin-1 has been correlated with tumorigenesis and/or metastasis (Miwa et al. 2000) . The loss of membrane claudin expression and its re-localization to the nucleus and cytoplasm has been previously reported for both human colon (Dhawawn et al. 2005) and breast cancer (Kominsky et al. 2003) . Down-regulation of claudin-7 expression has been reported in human breast cancer (Kominsky et al. 2004 ) and in canine mammary gland cancers (Jakab et al. 2008c ). Claudin expression is lost as both the direct result of protein down-regulation as well as phosphorylation by MAP kinase (Fujibe et al. 2004) , protein kinase C (Banan et al. 2005) , cAMP-dependent protein kinase (D'Souza et al. 2005) and WNK-4 kinase leading to junction disruption and cytoplasmic internalization (Yamauchi et al. 2004) . Further functional studies are needed to clarify the biological role of mislocalization of claudin-7, from the cell membrane to the cytoplasm, in carcinomas of the canine hepatoid gland tumour.
In conclusion, the results of the present study have shown intense typical membraneexpression of claudin-7 in canine normal hepatoid gland, hyperplasia, adenoma, welldifferentiated and poorly differentiated carcinoma of this gland. In intact glands, hyperplasias, adenomas of the canine hepatoid gland, intact, hyperplastic and neoplastic basal cells never expressed claudin-7 molecule. Epitheliomas of the canine hepatoid gland were negative for claudin-7 molecule. Intense membrane-bound claudin-7 immunoreactivity was found in well-differentiated carcinomas, in addition claudin-7 overexpression in poorly differentiated carcinomas of the canine hepatoid gland. Claudin-7 seems to be one of the integral constituents of tight junction structures of intact canine hepatoid gland. In addition, claudin-7 seems to be helpful in distinguishing well-differentiated carcinomas and poorly differentiated carcinomas from epitheliomas of the canine hepatoid gland; and it can help distinguish well-differentiated carcinomas from adenomas arising from the canine hepatoid gland. In well-differentiated carcinomas, 10-30% tumour cells, and in poorly differentiated hepatoid gland carcinomas, 10-40 % neoplastic cells showed cytoplasmic positivity for claudin-7 with or without the typical membrane expression of claudin-7 protein. Further functional studies are needed to clarify the biological role of mislocalization of claudin-7 from the cell membrane to the cytoplasm in the carcinomas of the canine hepatoid gland tumour. 
